Summit Headlands, LLC

Portland, Oregon 97210

1 studies enrolling now · 11 studies all time

What they study most

Dementia With Lewy Bodies, Early Alzheimer's Disease, Generalized Anxiety Disorder, Lower Respiratory Tract Illness, Major Depressive Disorder, Obesity, Obesity and Overweight, Rheumatoid Arthritis, SARS-CoV-2

Studies at this site

• RE104 Safety and Efficacy Study in Generalized Anxiety Disorder — Recruiting now
• Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity — Running, not enrolling
• A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage) — Running, not enrolling
• Expanded Access Program for CT1812 (Zervimesine) — NO_LONGER_AVAILABLE
• Study of GS-0272 in Participants With Rheumatoid Arthritis — Stopped early
• A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19) — Running, not enrolling
• Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD) — Completed
• Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies — Completed
• Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease — Running, not enrolling
• A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833 — Completed